| 129618-40-2 |
| Viramune |
| BI-RG-587 |
| Nevirapine anhydrous |
| Viramune XR |
| BIRG 0587 |
| Nevirapine, anhydrous |
| Nevirapine teva |
| BIRG587 |
| BIRG-0587 |
| 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one |
| Nevirapina |
| 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE |
| 99DK7FVK1H |
| Nevirapinum anhydrous |
| NSC-641530 |
| BIRG0587 |
| DTXSID7031797 |
| CHEBI:63613 |
| NSC641530 |
| 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- |
| DTXCID9010787 |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
| BI RG 587 |
| nevirapinum |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-10-one |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
| 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- |
| Hemihydrate, Nevirapine |
| RefChem:853798 |
| J05AG01 |
| NEVIRAPINE TABLETS FOR ORAL SUSPENSION |
| 603-345-0 |
| 4-amino-1-((2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl)pyrimidin-2-one |
| NVP |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| BI-RG 587 |
| MFCD00866928 |
| BIRG-587 |
| CHEMBL57 |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one |
| 11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE |
| NEV |
| MLS000084585 |
| NCGC00065890-02 |
| SMR000048458 |
| S1742 |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
| Viramune(TM) |
| Viramune (TN) |
| CAS-129618-40-2 |
| HSDB 7164 |
| Nevirapine & CD4-IgG |
| Nevirapine & PRO 140 |
| UNII-99DK7FVK1H |
| NSC 641530 |
| Nevirapine (JAN/USP/INN) |
| Nevirapine) |
| 11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one |
| BIRG 587 |
| Nevirapine RS |
| NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE |
| Viramune IR |
| 1vrt |
| 2hny |
| Nevirapine [USAN:USP:INN:BAN] |
| BI-RG-587 & CD4-IgG |
| Nevirapine (Standard) |
| Nevirapine (Viramune) |
| NEVIRAPINE [MI] |
| Opera_ID_934 |
| NEVIRAPINE [INN] |
| NEVIRAPINE [JAN] |
| NEVIRAPINE [HSDB] |
| NEVIRAPINE [USAN] |
| NEVIRAPINE [VANDF] |
| Epitope ID:231711 |
| Nevirapine (anhydrous) CRS |
| NEVIRAPINE [MART.] |
| SCHEMBL3318 |
| NEVIRAPINE [WHO-DD] |
| MLS000759409 |
| MLS001055309 |
| MLS001201730 |
| MLS001424058 |
| MLS006011423 |
| BIDD:GT0326 |
| NEVIRAPINE [EMA EPAR] |
| BDBM1434 |
| orb1308075 |
| orb3141273 |
| NEVIRAPINE [ORANGE BOOK] |
| SCHEMBL29393780 |
| SCHEMBL29614675 |
| SCHEMBL30267890 |
| GTPL12676 |
| NEVIRAPINE [EP MONOGRAPH] |
| NEVIRAPINE [USP IMPURITY] |
| HMS2051J09 |
| HMS2231O23 |
| HMS3264D21 |
| HMS3371E03 |
| HMS3393J09 |
| HMS3655I08 |
| HMS3715B10 |
| HMS5079D22 |
| NEVIRAPINE [USP MONOGRAPH] |
| Pharmakon1600-01503842 |
| ALBB-027264 |
| BSB41895 |
| MSK10168 |
| Tox21 110982 |
| Tox21_110982 |
| Tox21_200770 |
| AC-643 |
| AC1280 |
| BBL010768 |
| EBC-11254 |
| HY-10570R |
| NSC759902 |
| STK580320 |
| NEVIRAPINE ANHYDROUS [USP-RS] |
| NEVIRAPINE ANHYDROUS [WHO-IP] |
| AKOS005504351 |
| Nevirapine for peak identification CRS |
| Tox21_110982_1 |
| AB07544 |
| CCG-100939 |
| DB00238 |
| KS-5019 |
| NC00189 |
| NN15304 |
| NSC-759902 |
| NCGC00065890-03 |
| NCGC00065890-04 |
| NCGC00065890-05 |
| NCGC00065890-07 |
| NCGC00065890-14 |
| NCGC00258324-01 |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody) |
| HY-10570 |
| N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin |
| Nevirapine 100 microg/mL in Acetonitrile |
| SY009679 |
| BI-RG 587;NSC 641530;NVP |
| DB-041930 |
| N0922 |
| NEVIRAPINUM ANHYDROUS [WHO-IP LATIN] |
| NS00004959 |
| SW197569-2 |
| C07263 |
| D00435 |
| EN300-119500 |
| AB00393001-13 |
| AB00393001-15 |
| AB00393001_16 |
| AB00393001_17 |
| F358078 |
| Q263713 |
| BRD-K15502390-001-19-1 |
| BRD-K15502390-001-20-9 |
| F2173-0607 |
| Z1521553473 |
| Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard |
| Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard |
| Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one |
| 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one |
| 6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- |
| Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one |
| 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0,3,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one |
|
There are more than 10 synonyms. If you wish to see them all click here.
|